《中国糖尿病杂志》官方网站

20

您的位置:首页 > 中国糖尿病杂志 > 2016年 > 3期

持续皮下胰岛素注射后延长胰岛素治疗时间对胰岛功能影响的临床观察

来自:中国糖尿病杂志  编辑:朱常青 陈波 伍绍国 孙燕 李婉媚|点击数:|2016-04-05

摘要】  目的  观察持续皮下胰岛素注射后延长胰岛素治疗时间对伴高血糖的新诊断T2DM患者胰岛β细胞功能的影响。  方法  根据胰岛素治疗时间,将90例新诊断T2DM患者随机分成2周、3月及5月组,各30例,检测并比较各组治疗前后及治疗结束1年后胰岛β细胞功能。  结果  各组治疗后血糖均下降,胰岛β细胞功能改善,3月和5月组ΔI30/ΔG30高于2周组[1.87±0.44vs1.95±0.49vs 1.63±0.51),P<0.01]。治疗结束1年后,3月和5月组缓解率高于2周组(53.3% vs 63.3% vs 40.0%,P0.05),5月组高于3月组(P0.01);与非缓解组相比,缓解组HbA1c控制更好[(5.57±0.27% vs 7.76±0.55%P0.05],ΔI30/ΔG30增加[(1.39±0.78vs1.82±0.29),P0.05],胰岛β细胞分泌功能下降更少[(303.71±46.12vs 200.69±29.42),P0.05]。  结论  胰岛素强化治疗可改善新诊断T2DM患者胰岛β细胞功能,治疗延长至35个月可更好延缓胰岛β细胞功能减退。

关键词】  糖尿病,2型;胰岛素强化治疗;胰岛β细胞功能

Clinical observation of the effect of islet function in extend the duration of insulin treatment after the continuous subcutaneous insulin infusion therapy  ZHU Chang-qing, CHEN Bo, WU Shao-guo, et al. Department of Endocrinology, The Twelfth Affiliated Peoples Hospital of Guangzhou Medical College, Guangzhou 510620, China

Corresponding author: CHEN Bo, E-mail:cblinxiang726@163.com

Abstract】  Objective  To investigate of the effect of islet β cell function in extend the duration of insulin treatment after the continuous subcutaneous insulin infusion therapy in newly diagnosed type 2 diabetic patients (T2DM).  Methods  90 newly diagnosed T2DM were randomly divided into three groups with intensive insulin therapy for 2 weeks, 3 months and 5 months respectively. The islet β cell function was measured before and 1 year after treatment, and the differences were compared among each group. Results The plasma glucose was controlled well and the islet β cell function was significantly improved in each group after treatment. The ratio value of △I30/△G30  in group of 3 months, 5 months were higher than group of 2 weeks [(1.87±0.44) vs ( 1.95±0.49) vs (1.63±0.51),P﹤0.01]. At 1 year after treatment , HbA1c was significantly lower [(5.57±0.27)% vs ( 7.76±0.55)%P0.05], △I30/△G30 was higher [(1.39±0.78) vs (1.82±0.29)P0.05] and the descending rate of isletβcell function was slower [(303.71±46.12) vs (200.69±29.42)P0.05] in the remission group than the non-remission group (P0.05). The ratio of remission in group of 3 months and 5 months was  higher than 2 weeks [53.3% vs  63.3%vs 40.0%,P0.05]. Conclusion Intensive insulin therapy can significantly improve the isletβ cell function of newly diagnosed T2DM. An appropriate extension for 3-5months of insulin treatment can further prevent the descending of isletβcell function.

Key words  Diabetic mellitus, type 2;  Intensive insulin therapy;  Islet β cell function

上一篇:动态血糖监测系统联合胰岛素泵治疗新诊断2型糖尿病患者的疗效观察 下一篇:新诊断2型糖尿病患者胰岛素泵强化治疗后长期白蛋白尿发生风险的回顾性研究